Test |
In Range |
Out Of Range |
Units |
Reference |
Cortisol, PM |
13.8 |
|
mcg/dL |
3.1 - 16.7 |
|
Comp. Metabolic Panel |
Sodium |
139 |
|
mmol/L |
136 - 144 |
Potassium |
4.4 |
|
mmol/L |
3.6 - 5.1 |
Chloride |
101 |
|
mmol/L |
101 - 111 |
CO2 |
30 |
|
mmol/L |
22 - 32 |
Anion Gap |
8 |
|
|
2 - 14 |
Glucose |
117 |
|
mg/dL |
74 - 118 |
Blood Urea Nitrogen |
14 |
|
mg/dL |
8 - 20 |
Creatinine |
|
1.30 H |
mg/dL |
0.70 - 1.2 |
|
In response to the creatinine standardization program developed by National Kidney Disease Education Program (NKDEP), creatinine results are now being reported using IDMS traceable (Isotope Dilution Mass Spectrometry) method effective February 13, 2009 |
Calcium |
9.4 |
|
mg/dL |
8.9 - 10.3 |
Protein, Total |
6.4 |
|
gm/dL |
6.1 - 7.9 |
Albumin |
4.0 |
|
gm/dL |
3.5 - 4.8 |
AG Ratio |
1.7 |
|
|
|
AST (SGOT) |
24 |
|
u/L |
15 - 41 |
ALT (SGPT) |
19 |
|
u/L |
17 - 63 |
Alk Phosphatase |
55 |
|
u/L |
38 - 126 |
Bilirubin, Total |
1.0 |
|
mg/dL |
0.4 - 2.0 |
Estimated GFR |
|
L 55 |
ml/min/ |
> 60 |
|
GFR results for African Americans are typially 21% higher |
Magnesium |
2.4 |
|
mg/dL |
1.8 - 2.5 |
TSH |
1.42 |
|
uiu/mL |
0.35 - 5.50 |
|
Complete Blood Count |
WBC Count |
5.6 |
|
K/uL |
4.0 - 10.5 |
RBC Count |
|
L 4.21 |
M/uL |
4.7 - 6.0 |
Hemoglobin |
13.6 |
|
g/dL |
13.5 - 18 |
Hematocrit |
|
L 40.1 |
% |
42 - 52 |
MCV |
95.1 |
|
fl |
78 - 100 |
MCH |
|
32.4 H |
PG |
27 - 31 |
MCHC |
34.1 |
|
g/dL |
32 - 36 |
RDW |
13.5 |
|
% |
11.5 - 14.0 |
Platelet |
213 |
|
K/uL |
150 - 400 |
MPV |
7.4 |
|
fL |
6.0 - 9.5 |
Differential Type Automated |
|
|
|
|
Neutrophil % |
|
78.6 H |
% |
37 - 77 |
Lymphocyte % |
|
L 13.1 |
% |
24 - 44 |
Monocyte % |
6.7 |
|
% |
0 - 10 |
Eosinophil % |
1.0 |
|
% |
0 - 12 |
Basophil % |
0.6 |
|
% |
0 - 2 |
ABS Neutorphil |
4.4 |
|
K/uL |
1.5 - 6.6 |
ABS Lymphocyte |
|
L 0.7 |
K/uL |
1.5 - 3.5 |
ABS Monocyte |
0.4 |
|
K/uL |
< 1.0 |
ABS Eosinophil |
0.1 |
|
K/uL |
< 0.7 |
ABS Basophil |
0.0 |
|
K/uL |
< 0.1 |
|
25-Hydroxyvitamin D2 and D3, S |
25-Hydroxyvitamin D2 |
3.4 |
|
|
ng/mL |
25-Hydroxyvitamin D3 |
54.9 |
|
|
ng/mL |
25-Hydroxyvitamin D2 and D3 |
58.3 |
|
30.0 - 80.0 |
ng/mL |
|
Interpretive Information: 25-HydroxVitamin D2 and D3, Serum |
|
18 years and older: |
|
Deficiency: less than 20 ng/mL |
|
Insufficiency: 20 - 29 ng/mL |
|
Optimum Level: 30 - 80 ng/mL |
|
Possible Toxicity: Greaater than 150 ng/mL |
|
Performed by ARUP Laboratories, 500 Chipetaa Way, SLC, UT 84108 800-522-2787, www.aruplab.com, Sherrie L. Perkins, MD - Lab director |
|
Miscellaneous sendout test |
Metanephrines |
Specimen |
2 ml EDTA |
|
|
|
|
Test performed at: Assoc. Regional & University Pathologies, Inc., 500 Chipeta Way, Salt Lake City, Utah 84108 |
|
Testosterone, Total and Free, A |
Testosterone |
458.00 |
|
ng/dL |
71.8 - 623 |
Tanner Stage or Age (yrs) |
Male |
|
Female |
|
I (7 mo - 9 yrs) |
< 30 |
|
< 10 |
|
II (10 - 13) |
< 150 |
|
< 30 |
|
III (14 - 15) |
100 - 320 |
|
< 35 |
|
IV,V (16 - 19) |
200 - 970 |
|
15 - 40 |
|
|
Test performed at: HealthCare Clinical Lab, A member of Dignity Health, 2102 N CLIA #05D0609125, 1-888-LAB-HCCL, Medical director: Stephen G. Connolly, M.D. |
Sex Hormone Bind Glob |
77.3 |
|
10 - 57 |
nmol/L |
Testosterone, Free |
51.6 |
|
47.0 - 244.0 |
pg/mL |